Immediate Impact
40 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Advances in antibody-based therapy in oncology
2023 Standout
Works of Donatella Russo being referenced
MO-0049 SBRT in ovary cancer patients progressing within PARP-Inhibitor maintenance regimen:Epimetheo study
2023
Preliminary report of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine and daunorubicin in patients with acute myeloid leukemia
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Donatella Russo | 31 | 31 | 10 | 24 | 12 | 88 | |
| D. Zafiropoulos | 21 | 12 | 29 | 20 | 13 | 178 | |
| Hans Ulrich Ulmer | 12 | 26 | 32 | 12 | 12 | 145 | |
| Jarey H. Wang | 34 | 12 | 41 | 72 | 11 | 170 | |
| N. Antoniou | 60 | 9 | 31 | 12 | 15 | 114 | |
| Jürgen Schultze | 53 | 8 | 8 | 43 | 13 | 126 | |
| Marie Terroir-Cassou-Mounat | 10 | 16 | 18 | 19 | 9 | 92 | |
| Stacy R. Mettier | 23 | 33 | 17 | 14 | 12 | 164 | |
| Nikita Mehta | 37 | 21 | 9 | 4 | 13 | 117 | |
| L. Lamm | 8 | 34 | 11 | 16 | 12 | 178 | |
| JA Cairns | 31 | 7 | 8 | 10 | 8 | 80 |
All Works
Login with ORCID to disown or claim papers
Loading papers...